CClinicalTrials.gg
CompletedNCT01220193Updated Feb 18, 2011

Evaluation of RTVue in Corneal Measurement

An observational study in Normal Cornea, Post Laser Refractive Surgery and Cornea Pathology, sponsored by Optovue. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-02-18.

Sponsored by Optovue · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
196
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate RTVue measurement of the cornea in various ocular conditions to include normal, pathology, post refractive surgery and cataract.

02

Conditions studied

  • Normal Cornea
  • Post Laser Refractive Surgery
  • Cornea Pathology
  • Cataract Surgery
03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 196 is above the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Optovue is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Various ocular conditions to include normal, pathology, post refractive surgery and cataract.

Eligibility criteria

Inclusion Criteria:

Normal cornea:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery and no prior laser refractive surgery

Post laser refractive surgery:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery except laser refractive surgery
  • At least 1 week post laser refractive surgery without complication

Corneal pathology:

  • 18 years of age or older
  • Clinical diagnosis of one or more type of corneal pathologies, including corneal scar and keratoconus, etc., excluding eyes in which corneal power measurement are not clinically relevant (e.g., eyes requiring corneal transplant)
  • No prior laser refractive surgery

Cataract surgery:

  • 18 years of age or older
  • No corneal pathology
  • No prior ocular surgery, no prior laser refractive surgery, and no prior cataract surgery
  • Post surgery visit shall only include eyes without complication
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
196 participants (estimated)

Groups and cohorts

  • Normal cornea
  • Post laser refractive surgery
  • Cornea pathology
  • Cataract surgery
06

Study locations

2 sites
  • Gordon Binder & Weiss Vision Institute
    San Diego, California 92122, United States
  • Brass Eye Center
    Latham, New York 12110, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01220193
Lead sponsor
Optovue
First posted
Oct 13, 2010
Start date
Apr 2009
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Feb 18, 2011
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion